BridgeMD

Sign in

Mammography clinical trials

Explore recruiting mammography clinical trials.

Recruiting mammography studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mammography trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Role of contrast enhanced mammography with Iomeprol 400 mgI/ml (Iomeron, Bracco), in the identification of breast cancer: I3-MaC Study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

The role of Contrast-Enhanced Spectral Mammography (CESM) in the diagnostic process of breast cancer: can it improve specificity of first-line examinations and therefore reduce the suspicious lesions that undergo vacuum assisted breast biopsy (VABB)?

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

NeoAdjuvant Dynamic marker - Adjusted Personalized Therapy comparing sacituzumab govitecan+pembrolizumab vs. SoC chemotherapy in clinical stage II-III, triple-negative early breast cancer (ADAPT-TN-IV)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

NeoAdjuvant Dynamic marker - Adjusted Personalized Therapy comparing sacituzumab govitecan versus sacituzumab govitecan+pembrolizumab in low-risk, triple-negative early breast cancer (ADAPT-TN-III)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

18F-FES PET/MRI for tailoring treatment of luminal A and lobular breast cancer: a phase II trial evaluating the performance of FES PET/MRI in axillary staging

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Iodine Contrasts Effectiveness and Safety in Contrast Enhanced Mammography and breast magnetic resonance imaging.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mammography trials by city

Mammography in Toronto Mammography in Vancouver Mammography in Montreal Mammography in Calgary Mammography in Edmonton Mammography in Ottawa Mammography in Winnipeg Mammography in Quebec City Mammography in Hamilton Mammography in Kitchener Mammography in London Mammography in Halifax Mammography in New York Mammography in Los Angeles Mammography in Chicago Mammography in Houston